Hyperparathyroid Crisis: Use of Bisphosphonates as a Bridge to Parathyroidectomy
Authors:
- Roy PhitayakornRPRoy Phitayakorn
- Christopher R. McHenryCMChristopher R. McHenry
- 1 June 2008
- journal article
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 206 (6) , 1106-1115
Abstract
Hyperparathyroid crisis is an uncommon, potentially lethal condition for which emergent parathyroidectomy has been advocated. The manifestations of hyperparathyroid crisis and outcomes of bisphosphonate-based therapy and delayed parathyroidectomy were determined and compared with cases from a review of the literature. Laboratory indices and gland weights were compared with those from patients with primary hyperparathyroidism without crisis. Of the 292 patients operated on for hyperparathyroidism, 8 (2.8%) had hyperparathyroid crisis, consistent with rates of 1.6% to 6% reported in the literature. Hyperparathyroid crisis was manifested by vomiting, nausea, or both (n=6); abdominal pain (n=3); mental status changes (n=3); pancreatitis (n=2); bone pain, osteolytic lesions, or both (n=2); electrocardiogram changes (n=1); and an acute conversion disorder (n=1). Isotonic sodium chloride and furosemide, in combination with a bisphosphonate drug in 7 of 8 patients, resulted in a calcium decline from 16.2+/-1.6 mg/dL to 11.8+/-1.6 mg/dL, with resolution of electrocardiogram and mental status changes, and pancreatitis before resection of an adenoma (n=7) or carcinoma (n=1). Patients with hyperparathyroid crisis had higher parathyroid hormone levels (691.7 +/-662.4 pg/mL versus 172.6 +/-147.5 pg/mL; p=0.062), larger tumor weights (7.5 +/-8.4 g versus 1.6 +/-2.1 g; p=0.085), and lower postoperative calcium levels (7.3 +/-1.6 mg/dL versus 8.7+/-0.9 mg/dL; p=0.035) than patients without crisis. Four (50%) of the 8 tumors were found in ectopic locations. There was no mortality from hyperparathyroid crisis, compared with a 7% mortality rate for cases reported in the literature since 1978. Rehydration, calciuresis, and bisphosphonate therapy are effective in correcting life-threatening manifestations of hyperparathyroid crisis, providing an effective bridge to parathyroidectomy.Keywords
This publication has 53 references indexed in Scilit:
- Giant mediastinal parathyroid cyst: An unusual cause of hypercalcemic crisis—case report and review of the literatureSurgery, 1996
- Parathyroid storm: Immediate recognition and pathophysiological considerationsBone, 1993
- Herpes Zoster--Induced Acute Hyperparathyroid CrisisClinical Infectious Diseases, 1992
- Acute primary hyperparathyroidism: Experience of 59 casesBritish Journal of Surgery, 1989
- TREATMENT OF SEVERE HYPERCALCAEMIA WITH MITHRAMYCIN AND AMINOHYDROXYPROPYLIDENE BISPHOSPHONATEThe Lancet, 1988
- Acute Hyperparathyroidism Successfully Treated by Total Parathyroidectomy and Parathyroid AutotransplantationBritish Journal of Urology, 1986
- Hyperparathyroid CrisisAnnals of Surgery, 1979
- Hyperparathyroid Crisis A Collective ReviewAnnals of Surgery, 1967
- Hyperparathyroid CrisisAnnals of Surgery, 1965
- Pancreatitis, A Diagnostic Clue to HyperparathyroidsmAnnals of Surgery, 1957